1. AB0020 Comparison of synovial mmp-1 and timp-1 levels in patients with various inflammatory arthritides. (1st June 2001) Authors: Pay, S; Erdem, H; Serdar, M; Dinc, A; Simsek, I; Turan, M Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0188 Diastolic dysfunction in patients with scleroderma: a tissue doppler study. (1st June 2001) Authors: Dinc, A; Uzun, M; Pay, S; Simsek, I; Kilicarslan, F; Erdem, H Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0211 A descriptive analysis of real-world treatment patterns of innovator infliximab (REMICADE) and biosimilar infliximab in a treatment naÏve turkish rheumatologic disease population. (15th June 2017) Authors: Yazici, Y; Xie, L; Ogbomo, A; Parenti, D; Goyal, K; Teeple, A; Ellis, L; Simsek, I Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Response to Zizzo et al. (5th April 2013) Authors: Simsek, I; Yilmaz, S; Cinar, M; Erdem, H; Pay, S Journal: Clinical genetics Issue: Volume 83:Number 6(2013:Jun.) Page Start: 582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0175 A descriptive analysis of real-world treatment patterns in a turkish rheumatology population that continued innovator infliximab (REMICADE) therapy or switched to biosimilar infliximab. (15th June 2017) Authors: Yazici, Y; Xie, L; Ogbomo, A; Parenti, D; Goyal, K; Teeple, A; Ellis, L; Simsek, I Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 836 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗